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Abstract
Background: During the estrous cycle, the rat uterine endometrium undergoes many changes such as cell proliferation and
apoptosis. If implantation occurs, stromal cells differentiate into decidual cells and near the end of pregnancy, a second wave of
apoptosis occurs. This process called decidual regression, is tightly regulated as is it crucial for successful pregnancy. We have
previously shown that TGF-beta1, TGF-beta2 and TGF-beta3 are expressed in the endometrium during decidual basalis
regression, but although we had demonstrated that TGF- beta1 was involved in the regulation of apoptosis in decidual cells, the
ability of TGF- beta2 and TGF-beta3 isoforms to trigger apoptotic mechanisms in these cells remains unknown. Moreover, we
hypothesized that the TGF-betas were also present and regulated in the non-pregnant endometrium during the estrous cycle.
The aim of the present study was to determine and compare the specific effect of each TGF-β isoform in the regulation of
apoptosis in sensitized endometrial stromal cells in vitro, and to investigate the regulation of TGF-beta isoforms in the
endometrium during the estrous cycle in vivo.
Methods: Rats with regular estrous cycle (4 days) were killed at different days of estrous cycle (diestrus, proestrus, estrus and
metestrus). Pseudopregnancy was induced with sex steroids in ovariectomized rats and rats were killed at different days (days
1–9). Uteri were collected and either fixed for immunohistochemical staining (IHC) or processed for RT-PCR and Western
analyses. For the in vitro part of the study, rats were ovariectomized and decidualization was induced using sex steroids.
Endometrial stromal decidual cells were purified, cultured and treated with different concentrations of TGF-beta isoforms.
Results: Our results showed that all three TGF-beta isoforms are present, but are localized differently in the endometrium
during the estrous cycle and their expression is regulated differently during pseudopregnancy. In cultured stromal cells, we found
that TGF-beta3 isoform induced Smad2 phosphorylation, indicating that the Smad pathway is activated by TGF-beta3 in these
cells. Furthermore, TGF-beta2 and TGF-beta3 induced a dose-dependant increase of apoptosis in cultured stromal cells, as
demonstrated by Hoechst nuclear staining. Noteworthy, TGF-beta2 and TGF-beta3 reduced the level of the anti-apoptotic XIAP
protein, as well as the level of phosphorylated/active Akt, a well known survival protein, in a dose-dependent manner.
Conclusion: Those results suggest that TGF-beta might play an important role in the remodelling endometrium during the
estrous cycle and in the regulation of apoptosis in rat decidual cells, in which inhibition of Akt survival pathway might be an
important mechanism involved in the regulation of apoptosis.
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Background
During the pre-implantation period, the uterine
endometrium undergoes morphological and histological
changes including cell proliferation, differentiation and
apoptosis to provide the best environment for embryo
implantation. Sex steroids, estrogen and progesterone, are
responsible for these changes during the estrous cycle.
Estrogen stimulate cell proliferation whereas progesterone
inhibits it [1,2]. Luminal and glandular epithelium as well
as stromal cells proliferate and degenerate in response to
cyclic changes in serum steroids hormones [3,4]. In
absence of embryonic factors, endometrial cells undergo
apoptosis or programmed cell death. However, when
embryo implantation occurs, many changes begin in the
endometrium in which stromal cells proliferate in
response to estrogen and progesterone to form the decid-
ual cells, a process called decidualization. [5,6]. Near the
end of the pregnancy, on day 14, decidual cells regress by
apoptosis, a phenomenon called decidual regression
[5,7,8]. Our group and others have shown apoptosis in
the luminal epithelium at estrus in mice [4] and rats [9-
11] during the estrous cycle; apoptosis was also found in
stromal cells at diestrus in mice [4]. We have previously
shown that Akt, an important kinase involved in the con-
trol of endometrial cell proliferation, was decreased at
estrus and was accompanied by an increase in apoptosis
in luminal epithelial cells [10]. Studies have shown that
apoptosis is increased in the rat endometrium during the
decidual regression [5,12,13]. Although changes in uter-
ine endometrium are regulated by steroids hormones [4],
they are also regulated by growth factors, such as trans-
forming growth factor-β (TGF-β).
Transforming growth factor-β was originally identified by
its ability to induce a transformed phenotype in normal
rat kidney fibroblasts in culture [14-16]. TGF-βs are now
known to be multifunctional proteins involved in many
biological processes such as cell proliferation and differ-
entiation, tissue remodelling, angiogenesis, immunoregu-
lation and regulation of extracellular matrix [17-20]. They
are also inhibitors of cellular growth in many cell types
[21]. It has been shown that they induce apoptosis [8] and
it might be through the caspases pathway [22,23]. Three
TGF-β isoforms are found in mammalians and their
molecular weights are slightly different: TGF-β1 (15 kDa),
TGF-β2 (12.5 kDa) and TGF-β3 (12 kDa). They share 80%
sequence homology and genes encoding these isoforms
are located on different chromosomes (chromosomes 19,
1 and 14 for TGF-β1, TGF-β2 and TGF-β3 respectively)
[17,19,24]. TGF-β are produced in an inactive form which
is activated by proteolytic cleavage [25]. Bioactive TGF-β
signals through transmembrane serine/threonine kinase
receptors to phosphorylate Smads proteins, the TGF-β
intracellular effectors. Once activated, these proteins
translocate to the nucleus, bind to DNA binding proteins
and activate transcription of target genes [18,25]. Loss of
TGF-β-mediated growth inhibition contributes to the
development and progression of tumors [21,26]. The high
degree of conservation of these isoforms among species
and through evolution suggests an important regulation
function [27]. Indeed, it has been shown that all three
TGF-β isoforms are differently expressed during embryo-
genesis [20,28], in porcine [29,30] and bovine [31] con-
ceptus-maternal interface and in the mouse uterus [32].
Moreover, we have shown in our laboratory that TGF-β
isoforms efficiently inhibit cellular proliferation in
human endometrial carcinoma cell lines and that TGF-β3
increases invasiveness of endometrial carcinoma cells
through PI 3-K upregulation of XIAP and protein kinase C
induction of MMP-9 [33].
Chegini et al showed by immunohistochemical analysis
(IHC) that TGF-β1, TGF-β2 and TGF-β3 are expressed in
the rat estrous cycle, but in a context of induced endome-
triosis [34]. Studies have also shown that apoptosis is
increased during the decidual regression [5,12,13]. TGF-
β1 and TGF-β2 mRNA are expressed in mouse uterus dur-
ing pregnancy [35,36], and TGF-β1 and TGF-β2 have been
shown to induce apoptosis in human [37] and rat cul-
tured [8] endometrial stromal cells. The role of TGF-β3 in
the process of decidual cell death has never been
described before. Recently, we showed that TGF-β iso-
forms are differently localized and regulated in endome-
trial cells of pregnant rats during implantation and
decidual regression, and that TGF-β1 is involved in the
regulation of apoptosis in cultured decidual cells [38].
Although the expression of TGF-β isoforms have been
described in uterus of pregnant rats, their expression dur-
ing the estrous cycle and their effect on decidual cell
regression remain to be explored.
The aim of this study was to investigate and characterize
the expression of all three TGF-β isoforms in the rat uterus
during the estrous cycle and to determine in vitro the spe-
cific effect of TGF-β2 and TGF-β3 on the regulation of sur-
vival of decidual cells. The current study is the first to
show the expression and localization of all three TGF-β
isoforms in the normal rat uterus and to provide evidence
for the regulation of TGF-β2 and TGF-β3 by sex steroids
using an artificially induced pseudopregnant rat model.
Additionally, this study shows for the first time the regu-
lation of Akt phosphorylation and XIAP expression in the
process of decidual cell death induced by TGF-β2 and
TGF-β3.
Methods
Reagents
TGF-β1 (sc-146, lot # F262, 200 μg/ml), TGF-β2 (sc-90,
lot # B202, 200 μg/ml) and TGF-β3 (sc-82, lot # A222,
200 μg/ml) polyclonal antibodies were purchased fromReproductive Biology and Endocrinology 2009, 7:80 http://www.rbej.com/content/7/1/80
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Santa Cruz Biotechnology, Inc (Santa Cruz, CA, USA).
CDC47/MCM7 antibody was obtained from Medicorp
(Montréal, QC, Canada). Phospho-Akt (Ser 473), Akt,
XIAP, and Phospho-Smad2 (Ser 465/467) antibodies
were obtained from Cell Signaling Technology (Beverly,
MA, USA). Anti-Smad2 antibody was purchased from
Zymed (San Francisco, CA, USA). β-actin antibody was
purchased from Sigma-aldrich (St-Louis, Missouri, USA).
Vectastain ABC Kit for rabbit IgG and NovaRed substrate
were purchased from Vector Laboratories Inc. (Burlin-
game, CA, USA). Rabbit IgG was used at the same concen-
tration as the primary antisera. Harris modified
haematoxylin solution was obtained from Sigma-aldrich
(St-Louis, Missouri, USA). TGF-β2 recombinant protein
was purchased from Biosource (Cat # PHG9114, lot #
19698-04S, 5 μg, diluted at 50 μg/ml, QC, Canada) and
TGF-β3 recombinant protein was purchased from Calbio-
chem (Cat # PF073, lot # D24438, 2 ug, diluted at 50 μg/
ml, San Diego, CA, USA). 17β-estradiol (E2) was pur-
chased from Sigma-aldrich (St-Louis, Missouri, USA) and
progesterone (P4) from Laboratoire Mat (Québec, QC).
Animals
Sprague-Dawley female rats, 200–225 g, were obtained
from Charles River Laboratories Canada. Animals were
maintained on standard chow and water, which were
available  ad libitum, in animal facilities illuminated
between 6:00 h and 20:00 h. All procedures were per-
formed in accordance with guidelines of the Canadian
Council on Animal Care for the handling and training of
laboratory animals and the Good Health and Animal Care
Committee of the Université du Québec à Trois-Rivières.
Stages of the estrous cycle were confirmed by vaginal
smears. Rats with three regular cycles of four days were
used in these experiments and killed at various stages of
the estrous cycle (diestrus, proestrus, estrus, metestrus).
Uteri were collected and fixed for immunohistochemical
staining (IHC) or endometrial RNA and protein extracts
collected by scraping the endometrium for RT-PCR and
Western analysis. To induce pseudopregnancy, rats were
ovariectomized for at least 10 days and then injected with
E2 and P4 as described previously [39] 1) 0.2 μg estradiol
injection per day for three days (in the morning, day -2, -
1 and 0); 2) On the third day (day 0 of pseudopregnancy),
another injection in the afternoon of estradiol (0.2 μg)
and progesterone (1 mg) was performed; 3) No treatment
for the next day; 4) Injections of progesterone (4 mg) for
two days (day 2 and 3 of pseudopregnancy); 5) Injections
of estradiol (0.3 μg) and progesterone (4 mg) for one day
(day 4 of pseudopregnancy); 6) Injections of estradiol
(0.1 μg) and progesterone (4 mg) for 5 days (days 5 to 9
of pseudopregnancy); 7) Rats were killed on day 1, 3, 5, 7
and 9 of pseudopregnancy. Three different rats were used
for each time of pseudopregnancy. Endometrial protein
extracts were collected by scraping the endometrium for
Western analysis. E2 and P4 were dissolved with sesame
oil, and administered by subcutaneous injection.
Rat pretreatments and decidual endometrial stromal cell 
culture
A total of 10 rats were ovariectomized and then allowed
to recover from surgery for a minimum of 10 days. They
were pre-treated with physiological doses of estradiol
(1,3,5(10)-Estratriene-3,17β-diol, Sigma-aldrich) and
progesterone (Laboratoire Mat, PQ) to induce deciduali-
zation as described previously [40]: 1) 0.2 ug estradiol
injection per day for three days (in the morning, day -2,-1
and 0); 2) On the third day (day 0 of pseudopregnancy),
another injection in the afternoon of estradiol (0.2 μg)
and progesterone (1 mg) was performed; 3) No treatment
for 2 days (day 1 and 2 of pseudopregnancy); 4) Injections
of estradiol (0.1 μg) and progesterone (4 mg) for three
days (day 3, 4 and 5 of pseudopregnancy); 5) Another
injection of estradiol (0.1 μg) in the afternoon on day 7
(day 4 of pseudopregnancy); 6) Rats were killed on day 8
(day 5 of pseudopregnancy). All endometrial stromal cells
collected for cultures were recovered from rats treated
with the protocol described above.
Uteri were removed and horns taken and immerged in
HBSS solution containing HEPES (20 mM), penicillin
(100 units/ml), streptomycin (100 μg/ml) and fungizone
(1,25 μl/ml) (Invitrogen, ON, Canada). Further manipu-
lations were performed in a sterile environment. The uter-
ine horns were transferred into a sterile petri containing
HBSS, slit longitudinally and immerse in trypsin type I
solution (0.3%) (Roche Diagnostics, QC, Canada) in
HBSS and agitated for 60 minutes at room temperature.
Uterine horns were then vortexed at maximum for 5 sec
and supernatant containing epithelial cells was discarded.
Uterine horns were washed three times with 2.5 ml of
HBSS and immersed in a HBSS solution containing
trypsin type I (0.03%), DNAse I (0.016%) and colla-
genase type II (0.064%) for 15 minutes at 37°C in a water
bath. Uterine horns were then vortexed at maximum for 5
sec. The supernatant containing stromal cells was trans-
ferred into a sterile falcon tube containing 150 μl of FBS
D.C (Dextran-Charcoal extracted). Uterine horns were
washed two times with 2.5 ml of HBSS and the superna-
tant was mixed with stromal cells. Uterine horns were dis-
carded and stromal cells were centrifuged at 1000 g for 5
minutes. Cells were washed two times with HBSS and cen-
trifuged. The supernatant was discarded and cells diluted
with DMEM-F12 (pH 7.1) (Invitrogen, ON, Canada) con-
taining 2.438 g/L NaHCO3, 10% FBS D.C. and gentamy-
cine 50 μg/ml. Cells were incubated at 37°C in an
atmosphere of 5% CO2. Cells were plated in 6-well plates
(Corning plates) at a density of 50% (4 × 105 cells per
well). The medium was changed two hours after the first
incubation in order to eliminate epithelial cell contami-Reproductive Biology and Endocrinology 2009, 7:80 http://www.rbej.com/content/7/1/80
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nation from stromal cell cultures. The purity of stromal
cells was more than 97%: cell culture contamination with
epithelial cells was evaluated by cellular morphology and
immunofluorescence using a Keratin 8/18 antibody.
Three to 5 days after plating (more than 90% of conflu-
ency reached), cells were treated for 24 hours in the pres-
ence or absence of increasing doses of TGF-β2 and TGF-β3
recombinant proteins. Total proteins from treated cell cul-
tures were extracted using TRIZOL (Invitrogen, ON, Can-
ada). For Western blot analyses, 10–15 μg of total protein
per gel lane were used for each analysis.
Immunohistochemical staining
The uterus was fixed in 4% paraformaldehyde solution
and embedded in paraffin. Tissue sections 7 μm thick
were mounted on polylysine-coated slides, deparaffin-
ized, rehydrated, and then heated in 10 mM citrate buffer
(pH 6) containing triton X-100 (Sigma-Aldrich) 0.1% (v/
v). After two washes with PBS, slides were then incubated
with 0.3% hydrogen peroxide in methanol for 30 min to
quench endogenous peroxidase activity. After washing
with PBS, tissues were incubated with blocking serum
(Vectastain ABC Kit) at room temperature for 1 h. Then, a
primary antibody diluted in blocking serum (TGF-β1, β2
or β3; 1:50 dilution) was added to the slides and incu-
bated at 4°C overnight in a humidified chamber. After
washing 5 min. in PBS, tissue sections were incubated for
30 min. with 3 μg/ml biotinylated antibody (anti-rabbit).
Subsequently, slides were washed with PBS and incubated
with avidin-biotin complex reagent containing horserad-
ish peroxidase for 30 min. Slides were washed with PBS
for 5 min and color development was achieved using
NovaRed substrate. The tissue sections were counter-
stained with haematoxylin. Negative controls were per-
formed using the same protocol but substituting the
primary antibody with normal rabbit IgG (Vector Labora-
tories Inc., Burlingame, CA, USA).
mRNA extraction and semi-quantitative RT-PCR analysis
Endometrium from each uterus of cycling rats was scraped
using a glass microscope slide and homogenized using a
pipette in TRIZOL (Invitrogen, ON, Canada). mRNA
extraction was performed according to the manufacturer's
instructions and diluted in RNAse-free DEPC water
treated. In order to measure abundance of TGF-β1, TGF-
β2, TGF-β3 mRNAs, primers were chosen as described
below and tested with different primer concentrations.
Total RNA (0.2 μg/μl) was used for preparation of first
strand cDNA by reverse transcriptase (RT). The RNA sam-
ples were incubated (65°C, 10 min) with 2 ul oligo dT
(deoxythymidine) primers in a final volume of 10 μl.
Samples were then incubated (37°C, 60 min) in 20 μl of
a reaction buffer (1×) containing dithiothreitol (DTT; 100
mM), deoxynucleotide triphosphates (dNTPs; 5 mM),
and Muloney murine leukemia virus reverse transcriptase
(MMLV-RT; 200 U/μl). After DNA synthesis, the reaction
volumes were brought up to 60 μl with autoclaved water.
A negative control was also included, using the same reac-
tion mixture but without RNA to ensure absence of any
contaminating genomic DNA in the RNA template. Rat
TGF-β1 a 501 pb mRNA (572–1072 bp; Genbank acces-
sion number X52498) was amplified using sense primer
5'-CTGTCCAAACTAAGGCTCGC-3' and antisense primer
5'-ACTGAAGCGAAAGCCCTGTA-3'. For TGF-β2 mRNA,
the expression was determined by amplification of 707 bp
(143–849 bp; Genbank accession number NM_031131)
and the sequence of the primers were 5'-ATCCTAGCCAG-
GGACGTTTT-3' (sense) and 5'-CGAAAGACCCT-
GAACTCTGC-3' (antisense). Expression of TGF-β3 mRNA
was determined by amplification of 681 bp (663–1343
bp; Genbank accession number NM_013174). Amplifica-
tion was carried out using the sense upstream sequence
5'GAAGGCTGCACTCAGGAAAC-3' and the antisense
downstream sequence 5'-GCAGTTCTCCTCCAAGTTGC-
3'. Rat β-actin mRNA was amplified using sense primer 5'-
GAGGATCTTCATGAGGTAGTCTGTCAGGTC-3' and anti-
sense primer 5'-CAACTGGAACGACATGGAGAAGATCT-
GGCA-3'. Each reaction mixture (final volume 50:1)
contains RT template or negative control (5:1), MgCl2 (50
mM), primers (10 μM), and Taq DNA polymerase (5 U/
μl). The PCR cycling conditions (35 cycles except for β-
actin 25 cycles) chosen were 30 sec at 94°C, 30 sec at
58°C (TGF-β1 and TGF-β2) and 55°C (TGF-β3) and 30
sec (TGF-β1) and 1 min (TGF-β2 and TGF-β3) at 72°C,
followed by a 5 min extension at 72°C. Reaction products
were analyzed on 1.0% agarose gels. Bands were visual-
ized by ethidium bromide staining. Densitometrical anal-
yses were performed (mRNA of interest and β-actin) using
the GelDoc 2000 and the Quantity One software (Bio-
Rad, Mississauga, ON, Canada). Optimizations for all set
of primers were performed prior analyses. All PCR reac-
tions were analysed during the linear amplification phase.
Results are expressed as a ratio (mRNA of interest/β-actin)
to correct for loading for each endometrial sample.
Protein extraction and Western analysis
Endometrium from each uterus of cycling and pseudo-
pregnant rats was scraped using a glass microscope slide
and homogenized using a pipette in TRIZOL (Invitrogen,
ON, Canada). Protein extraction was achieved according
to the manufacturer's instructions and diluted in 1% SDS.
Homogenates were centrifuged to remove insoluble mate-
rial. The supernatant was recovered and stored at -20°C
pending analysis. Protein content was determined with
the Bio-Rad DC Protein Assay. Protein extracts (50 μg)
were heated at 94°C for 3 min, resolved by 12–15% SDS-
PAGE and electrotransferred to nitrocellulose membranes
using a semidry transfer (Bio-Rad, Mississauga, ON). The
membranes were then blocked 2 h at room temperature
with PBS containing 5% milk powder, then incubatedReproductive Biology and Endocrinology 2009, 7:80 http://www.rbej.com/content/7/1/80
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with TGF-β1, TGF-β3 1:750; TGF-β2 1:2000; P-Smad2
(Ser 465/467) 1:1000; Smad2 1:1000; Akt 1:1000; Phos-
pho-Akt 1:1000; XIAP 1:1500; CDC47/MCM7 1:1000
and cleaved caspases-3 1:1000 and subsequently with
horseradish peroxidase-conjugated anti-rabbit or anti-
mouse secondary antibody (1:3000; room temperature
for 45 min). All membranes were stripped with Restore
western blot stripping buffer (Pierce, # 21059, lot #
FH71541), reprobed with an antibody specific to β-actin
which was used as an internal standard. Peroxidase activ-
ity was visualized with the Super signal® West Femto max-
imum sensitivity substrate (Pierce, Arlington Heights, IL,
USA), according to the manufacturer's instructions. Signal
was visualized using the Biochemi Imaging System (UVP,
CA, USA). Densitometrical analyses were performed (pro-
tein of interest and β-actin) using the GelDoc 2000 and
the Quantity One software (Bio-Rad, Mississauga, ON,
Canada). Results are expressed as a ratio (protein of inter-
est/β-actin) to correct for loading for each endometrial
sample.
Hoechst nuclear staining
Following TGF-β treatment, both floating and attached
cells were resuspended in PBS containing Hoechst 33258
for 24 hours at 4°C. Hoechst nuclear staining was viewed
and photographed using a Olympus BX60 fluorescence
microscope and a Coolsnap-Pro CF digital Camera
(Carsen Group, ON, Canada). Cells with typical apoptotic
nuclear morphology (nuclear shrinkage, condensation
and fragmentation) were identified and counted using
randomly selected fields on numbered photographic
slides, of which the "counter" was not aware of the treat-
ment, so as to avoid experimental bias. A minimum of
200 cells per treatment group were counted in each exper-
iment.
Statistical analysis
Western analyses of cycling and pseudopregnant animals
were repeated three to four times with samples collected
from 3–4 different rats/day of pregnancy. Endometrial
extracts from each rat were assessed individually. Western
analyses of cultured decidual cells were repeated 4 times
for each TGF-β dose (for each culture experiment, decid-
ual cells were recovered from a pool of ten different ova-
riectomized/treated rats). Results subjected to statistical
analyses were expressed as mean ± SEM. Data were sub-
jected to one-way ANOVA (PRISM software version 4.0;
GraphPad, San Diego, CA). Differences between experi-
mental groups were determined by the Tukey's test.
Results
Regulation of TGF- 1,  2 and  3 in the rat endometrium 
during the estrous cycle
To evaluate gene expression of TGF-β isoforms in rat
endometrium during the estrous cycle, rat uteri where col-
lected at each stage of the estrous cycle, total endometrial
RNA was extracted and RT-PCR analysis was carried out
using specific primers derived from rat DNA sequences.
Our results showed that all three TGF-β isoforms were
expressed throughout the estrous cycle. TGF-β 1 transcript
levels tended to be higher at proestrus and estrus (Fig. 1A).
TGF-β2 mRNA levels was similar at all days of estrous
cycle, except at proestrus where it tended to decrease (Fig.
1B), and TGF-β3 mRNA levels were significantly increased
(p < 0.05) on diestrus compared to other stages of the
cycle (Fig, 1C).
To characterize TGF-β protein expression in rat
endometrium during the estrous cycle, Western Blot and
immunohistochemical analysis were performed on lysate
and uterine sections, respectively, of reproductive cycling
rats. Western blot analyses confirm that TGF-β isoforms
are present during the estrous cycle. TGF-β1 protein levels
tended to increase, although not significantly, during
TGF-β1 (A), TGF-β2 (B) and TGF-β3 (C) mRNAs abundance  during the estrous cycle as demonstrated by RT-PCR analysis Figure 1
TGF-β1 (A), TGF-β2 (B) and TGF-β3 (C) mRNAs 
abundance during the estrous cycle as demonstrated 
by RT-PCR analysis. Total mRNA extracts from rat uteri 
were collected at each day of the estrous cycle. Data analy-
ses were performed by the Quantity One software and are 
presented as a ratio (value/β-actin). β-actin blots shown were 
used as controls to correct for loading in each lane. Results 
represent the mean ± SEM of four independent experiments 
(four different rats for each day of the estrous cycle). Col-
umns with different letters are significantly different from 
each other (P < 0.05).
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proestrus (Fig. 2A) as we observed with RT-PCR studies.
The expression of TGF-β2 proteins were increased during
diestrus but decreased at estrus (Fig. 2B). TGF-β3 proteins
were expressed in a similar pattern as observed with
mRNA expression; they were significantly increased dur-
ing diestrus (Fig. 2C), suggesting a possible role for this
isoform at diestrus.
As TGF-β2 and TGF-β3 seem to be regulated in a similar
pattern, we have carried out immunohistochemical anal-
ysis to determine their localization into the non-pregnant
endometrium (Fig. 3). TGF-β2 and TGF-β3 were found
both in luminal and glandular epithelial and stromal cells
at all days of the reproductive cycle. However, it is inter-
esting to observe that TGF-β1 is also found at each days of
the estrous cycle but only in stromal cells (Fig. 3) suggest-
ing that the action of TGF-β1 might be limited to the stro-
mal compartment.
Regulation of TGF- s and apoptosis in the rat endometrium 
during pseudopregnancy
In order to determine if the expression of TGF-β isoforms
in the endometrium during pregnancy is dependant on
the presence of a conceptus, we performed western blot
analysis on endometrial protein extracts from a model of
pseudopregnant rats. TGF-β1 expression was detected at
all days of pseudopregnancy without significant differ-
ence and levels tended to increase on days 5 (implanta-
tion) and was maximal at day 9 (Fig. 4A). TGF-β2 was
present only from day 7 of pseudopregnancy where its
expression increased strongly on day 9 (Fig. 4B). How-
ever, TGF-β3 was not expressed during pseudopregnancy
(Fig. 4C) suggesting that it may not be regulated and
involved during early pregnancy.
It has been shown that apoptosis of epithelial endome-
trial cells is required for embryo implantation [13]. To
determine the presence of apoptosis in the endometrium
during pseudopregnancy, we have measured the levels of
cleaved caspase-3, a well known executioner of apoptosis
[41]. Our results show that cleaved caspase-3 is increased
from day 5, day at which embryo implantation occurs, to
day 9 of pseudopregnancy (Fig. 4D), indicating that apop-
tosis can occur during the implantation period in the
absence of embryonic factors.
Effect of TGF- 2 and TGF- 3 on P-Akt and XIAP protein 
levels in decidual cells
We have previously shown that TGF-β1 down-regulates p-
Akt (phosphorylated/activated form of the cell survival
factor Akt) and XIAP (x-linked inhibitor of apoptosis) lev-
els in rat decidual cells [38]. To determine the effect of
TGF-β2 and TGF-β3 isoforms on the expression of cell sur-
vival protein, such as Akt and XIAP, and to further charac-
terize the relationship between TGF-β and PI3-K/Akt
pathways in decidual cells, Western blot analysis was per-
formed on cultured decidual stromal cells treated with dif-
ferent dose of TGF-β2 and TGF-β3. The results showed
that total Akt protein level is not influenced by TGF-β2
and TGF-β3 treatments and no significant variation was
observed (Fig. 5A and 6A respectively). However, phos-
phorylated Akt (p-Akt), the active form of Akt, was
decreased in a dose-dependant manner in response to
TGF-β2 and TGF-β3 treatments (Fig. 5B and 6B respec-
tively), suggesting an interaction between TGF-β isoforms
and PI3-K/Akt pathway in these cells. TGF-β has been
reported to regulate XIAP levels in several cell types such
as in endometrial carcinoma cells [33], and we investi-
gated whether down-regulation of Akt survival pathway
activity in rat decidual cells by TGF-β2 and TGF-β3 was
accompanied by a decrease in the levels of anti-apoptotic
TGF-β1 (A), TGF-β2 (B) and TGF-β3 (C) protein expression  during the estrous cycle as determined by Western blot anal- ysis Figure 2
TGF-β1 (A), TGF-β2 (B) and TGF-β3 (C) protein 
expression during the estrous cycle as determined by 
Western blot analysis. Total proteins extracts from rat 
uteri were collected at each days of the estrous cycle. β-actin 
blots shown were used as controls to correct for loading in 
each lane. Blots shown are from one representative experi-
ment. Graphics represent Western blot densitometrical anal-
ysis. Data represent the mean ± SEM of four independent 
experiments (four different rats for each day of the estrous 
cycle). Columns with different letters are significantly differ-
ent from each other (P < 0.05).
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XIAP protein. Similar to TGF-β1, which we previously
shown to reduce XIAP levels in rat cultured decidual cells
[38], we found that XIAP levels were also reduced in a
dose-dependant manner in response to TGF-β2 and TGF-
β3 treatments (Fig. 5C and 6C respectively).
TGF- 3 activates Smad2 in rat decidual cells
Smads proteins are known so far to be the TGF-β type I
receptor substrates that elicit signalling function in
response to TGF-β[25]. Western blot analysis was carried
out to determine the intracellular mechanism of TGF-β
isoforms action in rat decidual cells, and we specifically
investigated Smad signalling components. Figure 7 show
that there is no significant difference in the expression of
Smad2 protein in response to TGF-β2 (Fig. 7A) and TGF-
β3 (Fig. 8A) treatments. Phospho-Smad2, the activated
form of Smad2 protein, was not influenced by TGF-β2
(Fig. 7B), however it was significantly increased in
response to TGF-β3 treatment (Fig. 8B), indicating that
TGF-β3 triggers Smad signalling in rat decidual cells, nota-
bly involving Smad2.
TGF- 2 and  3 isoforms effect on decidual endometrial 
stromal cell fate
Transforming growth factor-beta isoforms are multifunc-
tional proteins involved in many cellular processes like
cell proliferation, differentiation and apoptosis and these
actions are depending of the tissue [17]. We have previ-
ously determined that TGF-β1 decreased decidual cell pro-
liferation [38]. We have performed Western blot analysis
using CDC-47, a cell proliferation marker, to determine
the proliferative action of the TGF-β2 and TGF-β3 iso-
forms on decidual stromal cells. Results show that CDC-
47 levels were not significantly modulated in response to
TGF-β2 and TGF-β3 treatments (Fig. 9A and 9B) suggest-
ing that TGF-β2 and TGF-β3 do not influence decidual cell
growth.
It was already demonstrated that TGF-β induced apoptosis
in rat endometrium [8]. To evaluate whether TGF-β2 and
TGF-β3 induce apoptosis in rat decidual cells, we have car-
ried out Hoechst nuclear staining on cultured decidual
cells treated with different doses of TGF-β2 and TGF-β3.
Our results demonstrate that both TGF-β isoforms
induced cell death in a dose-dependent manner (Fig. 9C
and 9D), however the increase of cell death was lower
compared to TGF-β1-induced cell death in the same type
of cells [38].
Discussion
Although TGF-β isoforms have been shown to be regu-
lated in the rat endometrium during pregnancy [38], little
is known about their expression during the estrous cycle
and their action on endometrial decidual cell regression.
The aim of this study was to investigate and characterize
the expression of TGF-β isoforms in the rat endometrium
throughout the estrous cycle and during pseudopregnancy
and to determine the specific effect of TGF-β2 and TGF-β3
in vitro on rat endometrial decidual cell fate. The present
results revealed that TGF-β isoforms are differently regu-
lated during the estrous cycle and pseudopregnancy and
they mediate apoptosis of decidual cells.
During the estrous cycle, the uterine endometrial cells
undergo proliferation, differentiation and apoptosis in
response to the steroids hormones, estrogen and proges-
Immunohistochemistry of TGF-β1, TGF-β2 and TGF-β3 in  rat endometrium during the estrous cycle Figure 3
Immunohistochemistry of TGF-β1, TGF-β2 and TGF-
β3 in rat endometrium during the estrous cycle. IHC 
shown are from one representative experiment and were 
repeated four times using four different uterine sections 
from four different rats per day of the estrous cycle. Repre-
sentative days of estrous cycle are presented (diestrus; proe-
strus; estrus; metestrus). C-: negative control. LE: luminal 
epithelium; S: stroma. Magnification: 400×.
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terone, to create a suitable environment for blastocyst
implantation [42]. Moreover, a complex, precise, and
highly interactive array of biological communication
pathways involving the action of steroids in concert with
local growth factors and cytokines is required to orches-
trate the controlled growth and differentiation of the
endometrial cells in the uterus [43]. TGF-β isoforms are
known to be implicated in diverse physiological processes
and they regulate cell proliferation, differentiation and
apoptosis. Since all of these events take place in the
endometrium during the estrous cycle [44], TGF-β iso-
forms must be an important growth factor involved dur-
ing the reproductive cycle. We have thus characterized the
expression of TGF-β in the endometrium of cycling rats.
Our results show that the three mammalian TGF-β iso-
forms are present during all stage of the estrous cycle,
which is consistent with a previous study that showed,
using immunohistochemical analysis that TGF-β isoforms
are expressed in rat endometrium during the cycle [34]. It
is known that apoptosis is present in rat endometrium
during the estrous cycle [9] and that TGF-β induce apop-
tosis in rat endometrial stromal cells [8]. In the present
study, TGF-β1 expression tended to be increased during
proestrus even though no significant difference was
observed and it was localized only in stromal cells sug-
gesting a role for this isoform in the remodelling of stro-
mal tissue. Additionally, we have demonstrated that TGF-
β2 and TGF-β3 expression was increased during diestrus,
which is in accordance with the results of Chegini et al
[34], and they were localized in both epithelial and stro-
mal cells suggesting that these two isoforms might be nec-
essary to induce apoptosis in stromal cells during diestrus
stage. This result is in accordance with a previous study
showing that apoptosis was increased in stromal cells dur-
ing diestrus in the mouse [4]. However, we and other have
previously shown the presence of apoptosis in rat uterine
epithelial cells at estrus [10,45], but we found no increase
in TGF-β levels during estrus suggesting that TGF-β2 and
TGF-β3 might be involved in cellular processes other than
apoptosis in rat epithelial endometrial cells during the
estrous cycle. Alternatively, downstream components of
TGF-β receptor could be differently regulated in distinct
cells of the same tissue resulting in increased sensitivity to
TGF-β1 (A), TGF-β2 (B), TGF-β3 (C) and Cleaved Caspase-3  (D) proteins expression during the pseudopregnancy as  determined by Western blot analysis Figure 4
TGF-β1 (A), TGF-β2 (B), TGF-β3 (C) and Cleaved 
Caspase-3 (D) proteins expression during the pseu-
dopregnancy as determined by Western blot analy-
sis. Total proteins extracts were collected from uteri at each 
days of the pseudopregnancy. β-actin blots shown were used 
as controls to correct for loading in each lane. Blots shown 
are from one representative experiment. Graphics represent 
Western blot densitometrical analysis. Data represent the 
mean ± SEM of four independent experiments (four different 
rats for each day of the pseudopregnancy). Columns with dif-
ferent letters are significantly different from each other (P < 
0.05). C+: positive control for TGF-β3.
Expression of Akt (A), Phospho-Akt (B) and XIAP (C) in cul- tured rat decidual cells in vitro in response to TGF-β2 (ng/ mL) as demonstrated by Western blot analysis Figure 5
Expression of Akt (A), Phospho-Akt (B) and XIAP 
(C) in cultured rat decidual cells in vitro in response 
to TGF-β2 (ng/mL) as demonstrated by Western blot 
analysis. β-actin blots shown were used as controls to cor-
rect for loading in each lane. Blots shown are from one rep-
resentative experiment. Graphics represent Western blot 
densitometrical analysis. Data represent the mean ± SEM of 
four independent experiments. Columns with different let-
ters are significantly different from each other (P < 0.05).
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TGF-β induced apoptosis in rat stromal endometrial cells
during diestrus.
The high levels of TGF-β2 and TGF-β3 at diestrus are cor-
related with elevated levels of serum progesterone at this
time. Indeed, Dharma et al [4] showed in the uterine
endometrium of the mouse that serum progesterone lev-
els were high during metestrus, the day before diestrus.
Moreover, studies showed that estrogen induces uterine
epithelial cell proliferation and estrogen withdrawal
results in cell death [10,46], which might suggests that
epithelial cell apoptosis in the uterine endometrium is
regulated by estrogen while stromal cell apoptosis might
be regulated by progesterone [4]. Since some evidence
suggests that steroid action stimulates the local produc-
tion of growth factors and their receptors [47,48] and that
growth factors have been implicated in mediating the
action of steroid hormones [47-49], TGF-β might play a
Expression of Akt (A), Phospho-Akt (B) and XIAP (C) in cul- tured rat decidual cells in vitro in response to TGF-β3 (ng/ mL) as demonstrated by Western blot analysis Figure 6
Expression of Akt (A), Phospho-Akt (B) and XIAP 
(C) in cultured rat decidual cells in vitro in response 
to TGF-β3 (ng/mL) as demonstrated by Western blot 
analysis. β-actin blots shown were used as controls to cor-
rect for loading in each lane. Blots shown are from one rep-
resentative experiment. Graphics represent Western blot 
densitometrical analysis. Data represent the mean ± SEM of 
four independent experiments. Columns with different let-
ters are significantly different from each other (P < 0.05).
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Expression of Smad2 (A) and Phospho-Smad2 (B) in cultured  rat decidual cells in vitro in response to TGF-β2 (ng/ml) as  demonstrated by Western blot analysis Figure 7
Expression of Smad2 (A) and Phospho-Smad2 (B) in 
cultured rat decidual cells in vitro in response to 
TGF-β2 (ng/ml) as demonstrated by Western blot 
analysis. β-actin blots shown were used as controls to cor-
rect for loading in each lane. Blots shown are from one rep-
resentative experiment. Graphics represent Western blot 
densitometrical analysis. Data represent the mean ± SEM of 
four independent experiments.
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Expression of Smad2 (A) and Phospho-Smad2 (B) in cultured  rat decidual cells in vitro in response to TGF-β3 (ng/ml) as  demonstrated by Western blot analysis Figure 8
Expression of Smad2 (A) and Phospho-Smad2 (B) in 
cultured rat decidual cells in vitro in response to 
TGF-β3 (ng/ml) as demonstrated by Western blot 
analysis. β-actin blots shown were used as controls to cor-
rect for loading in each lane. Blots shown are from one rep-
resentative experiment. Graphics represent Western blot 
densitometrical analysis. Data represent the mean ± SEM of 
four independent experiments. Columns with different let-
ters are significantly different from each other (P < 0.05).
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similar role in the induction of progesterone-mediated
apoptosis during the estrous cycle. A recent study showed
that Smad2, a component of the TGF-β intracellular sign-
aling pathway, was highly expressed in the luminal and
glandular epithelium at diestrus and proestrus while it
was decreased at estrus and metestrus [50] suggesting that
TGF-β might play an important role through Smad2 in tis-
sue remodelling in the cycling rat endometrium.
Other roles than apoptosis induction can be suggested for
TGF-β during the estrous cycle. It has been shown that
TGF-β is a potent chemoattractant for macrophages [19]
and monocytes [20], suggesting a role for this growth fac-
tor in the elimination of dead cells before the next cycle
(the next ovulation) and in wound repair. Furthermore, it
has been shown that matrix metalloproteinase (MMP), an
important class of proteases involved in endometrial
remodelling, was present in the rat endometrium during
the estrous cycle; the presence of MMP-3, MMP-9 and
MMP-13 (primary source of collagenase activity first asso-
ciated with uterine involution) has been demonstrated in
the stromal cells of non-pregnant rat endometrium, while
epithelial cell-specific MMP-7 (first MMP protein linked
to matrix remodelling in the rodent uterus) has also been
demonstrated in the non-pregnant rat uterus [43]. A pre-
vious study showed that MMP-7 mRNA levels were
dependant on the estrous cycle and it was 3 to 4 fold
higher at estrus and diestrus compared to metestrus [51].
Both TGF-β and MMPs are recognized to have an action
on tissue remodelling, and TGF-β might act through the
regulation of MMP activity. In fact, it has been shown that
TGF-β plays an important role in the regulation of MMP
production in the endometrium during the menstrual
cycle in women [43,52]. However, little is known about
the interaction between TGF-β and matrix metalloprotei-
nase in the remodelling uterus in cycling rats and further
investigations have to be carried out.
During early pregnancy, uterine endometrium is alterna-
tively remodelled by sex steroid and growth factors to
allow embryo implantation and then decidual regression
near the end of pregnancy. Apoptosis has been shown to
occur during these two important processes [5,8,13]. Sev-
eral growth factors are produced and secreted by both
conceptus and maternal uterine tissues in embryo-
endometrial interactions during implantation and decid-
ual regression. We have previously demonstrated that
TGF-β isoforms are present and expressed differently in
the rat endometrium during pregnancy [38]. Since the
induction of TGF-α gene expression has been shown to be
independent of the conceptus [53], we hypothesized that
it might be similar for TGF-β. Using the rat pseudopreg-
nancy model, which involves pregnancy-like remodelling
of the endometrium following exposure to steroid hor-
mones, we showed that TGF-β isoforms are differently
expressed and regulated in rat endometrial cells during
pseudopregnancy in a pattern similar to pregnant uterus
[38]. Notably, we have demonstrated that TGF-β1 was
present in all days of pseudopregnancy but its expression
was increased on day 5, day at which embryo implanta-
tion normally occurs, and was maximal on day 9 in a sim-
ilar pattern as compared to normal pregnancy [38],
strengthening our hypothesis that TGF-β1 might be
involved in the regulation of apoptosis during embryo
implantation and decidual regression, without the need
for signals from the embryo. TGF-β2 levels were shown to
be elevated only on day 9 of pseudopregnancy, and TGF-
β3 has not been detected during pseudopregnancy, simi-
larly to what was observed during normal pregnancy [38],
Expression of CDC-47 in cultured rat decidual cells in vitro in  response to TGF-β2 (A) and TGF-β3 (B) (ng/ml) as demon- strated by Western blot analysis Figure 9
Expression of CDC-47 in cultured rat decidual cells in 
vitro in response to TGF-β2 (A) and TGF-β3 (B) (ng/
ml) as demonstrated by Western blot analysis. β-actin 
blots shown were used as controls to correct for loading in 
each lane. Blots shown are from one representative experi-
ment. Graphics represent Western blot densitometrical anal-
ysis. C) and D) effect of TGF-β2 and TGF-β3 (ng/ml) on cell 
survival in cultured rat decidual cells as demonstrated by 
Hoechst nuclear staining. Data represent the mean ± SEM of 
four independent experiments. Columns with different let-
ters are significantly different from each other (P < 0.05).
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confirming that this isoform does not play a crucial role
during early pregnancy. This result is also supported by a
previous work demonstrating that TGF-β3 was absent dur-
ing early pregnancy in the mouse [32]. Altogether, our
results indicate that TGF-β isoforms expression is inde-
pendent of the conceptus (embryonic factors) and it
might be regulated by steroid hormones. Moreover, this
differential expression of TGF-β isoforms in the uterus
suggests distinctive functions of these growth factors dur-
ing early pregnancy.
Our results also show that apoptosis is induced during
pseudopregnancy. We have demonstrated that cleaved
caspase-3, a well known executioner of apoptosis [41],
was present in endometrium days 5 to 9 of pseudopreg-
nancy. Its levels were increased in a similar pattern than
what was observed during pregnancy [38] from day 5, day
at which embryo implantation occurs, to day 9 of pseudo-
pregnancy, indicating that the caspases pathway activa-
tion might be an important mechanism of cell death
involved in implantation and decidual regression.
Akt kinase is a key regulator of cell fate in numerous cell
types, including endometrial cells [10]; since TGF-β sig-
nalling pathway component Smad3 can directly interact
with Akt [53], we hypothesized that a crosstalk between
TGF-β and PI3-K/Akt signalling pathways could occur in
decidual cells which could dictate cell fate during preg-
nancy. It is already known that TGF-β1 induce apoptosis
in human [37] and rat [8] endometrial stromal cells, and
we have demonstrated in a previous work that TGF-β1 reg-
ulates the activity of PI3-K/Akt pathway, inducing a
decrease of Akt phosphorylation through a mechanism
involving Smad2 activation [38]. The present study shows
that, similar to TGF-β1 [38], TGF-β3 induces the phospho-
rylation/activation of Smad2 and decreases Akt phospho-
rylation/activation in a dose-dependant manner, and that
TGF-β2 also decreases Akt phosphorylation, although
likely in a Smad2-independent fashion. It is possible that
upon binding to its ligand TGF-β2, TGF-β receptor signals
through Smad3 rather than Smad2. Indeed, recent studies
showed that Akt interacts directly with Smad3 to regulate
the sensitivity to TGF-β-induced apoptosis [54,55], and
we hypothesize that TGF-β2 might decrease P-Akt levels
through Smad3 activation in rat decidual cells. Moreover,
the reduction of Akt phosphorylation in response to TGF-
β2 and TGF-β3 suggest that inhibition of Akt activity
might be an important mechanism by which these TGF-β
isoforms induce apoptosis in rat decidual cells.
Recent studies have shown the important interaction
between Akt and XIAP, a well known inhibitor of cas-
pases. It was shown that Akt phosphorylation is regulated
by XIAP in human ovarian epithelial cancer cells [56] and
in rat granulosa cells [57] and that phosphorylated Akt is
affected by the presence of cIAP-1 in endometrial cancer
cells [58]. More recently, we have shown that XIAP is an
E3 ubiquitin ligase for PTEN (phosphatase and tensin
homolog deleted on chromosome ten, a negative regula-
tor of Akt) and that degradation of PTEN through the pro-
teasome lead to the activation/phosphorylation of Akt
[59]. We have also previously shown that TGF-β1 reduced
XIAP protein levels in rat decidual cells, suggesting the
presence of a functional link between these two proteins
[38]. Here, we show that, in response to TGF-β2 and TGF-
β3, XIAP levels are decreased in a dose-dependant man-
ner. Studies have shown that XIAP can act as a cofactor in
the TGF-β signalling pathway [22,60]. Downregulation of
the anti-apoptotic factor XIAP is accompanied by a mod-
est but significant induction of apoptosis in rat decidual
cells exposed to TGF-β2 and TGF-β3, suggesting that XIAP
can inhibit apoptotic mechanisms in rat decidual cells.
A study showed that TGF-β1 and TGF-β2 treatments on
cultured stromal cells induce apoptosis [8]. In this paper,
we show that TGF-β2 and TGF-β3 have no effect on the
expression of CDC-47, a proliferation cell marker, sug-
gesting that these isoforms do not modulate cell prolifer-
ation of endometrial decidual cells although they weakly
induce cell death in a dose-dependant manner as demon-
strated by Hoechst nuclear staining. This is a surprising
observation, since increased cell death is usually accom-
panied by a decrease in cellular proliferation marker lev-
els. It is possible that other proliferation markers different
than CDC47 would be more relevant to decidual cells,
such as the proliferating cell nuclear antigen (PCNA) [61].
Moreover, the weak increase of apoptosis observed with
Hoechst staining might be accompanied by other types of
cell death such as autophagy, mitotic catastrophe or senes-
cence. Indeed, TGF-β has been showed to induce senes-
cence phenotype or to have a cytostatic action (cell cycle
arrest) on mammalian tissues [62].
Further investigation is thus needed to better understand
the interaction between TGF-βs and PI3-K/Akt pathway
and to determine how other factors that might be
involved in the regulation of TGF-β-mediated apoptosis
of decidual cells.
Conclusion
Taken together, these results show that the three TGF-β
isoforms are expressed and differently localized in the epi-
thelial and stromal cells during the estrous cycle, and that
they are differently regulated during pseudopregnancy in
a steroid hormone-dependent manner. Moreover, this
study shows that TGF-β signalling plays an important role
in the remodelling of rat endometrium by modulating the
activity of PI 3-K/Akt survival pathway, down-regulating
the anti-apoptotic XIAP levels and inducing apoptosis in
decidual cells. Future experiments will aim at better char-Reproductive Biology and Endocrinology 2009, 7:80 http://www.rbej.com/content/7/1/80
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acterize the underlying mechanisms such as the possible
interaction between TGF-β2 and Smad proteins in the
TGF-β-mediated apoptosis and the mechanism by which
TGF-β and Smads transducer proteins interact with PI 3-K/
PTEN/Akt survival pathway to induce apoptosis. Addi-
tional investigations will allow us to determine the pres-
ence of other type of programmed cell death such as
autophagy, senescence and mitotic catastrophe and how
they are involved in the rat endometrial decidual cell
death.
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